FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

The Marriott Inn and Conference Center, University of Maryland University College (UMUC) 

Potomac Ballroom, 3501 University Blvd. East, Hyattsville, Maryland 

 

September 12, 2014 

MEETING ROSTER 

 

 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Karen Abraham-Burrell, PharmD  
Division of Advisory Committee and Consultant Management 
Office of Executive Programs 
Center for Drug Evaluation and Research 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
Diana Hallare, MPH  
(Consumer Representative) 
Visalia, California 
 

Charles A. Stanley, MD 
Professor of Pediatrics 
Perelman School of Medicine University of 
Pennsylvania  
Division of Endocrinology & Diabetes 
Children’s Hospital of Philadelphia 
Philadelphia, Pennsylvania 
 
 

Robert J. Smith, MD 
(Chairperson) 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
Ocean State Research Institute 
Providence Veterans Administration Medical 
Center 
Providence, Rhode Island  
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER 
(Non-Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Project Vice President 
GLP-1 and Obesity – Global Development 
Novo Nordisk A/S.  
Novo Allé 1 
2880 Bagsvaerd 
Denmark 
 

 

Page 1 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

September 12, 2014 

 

 

MEETING ROSTER (cont.) 

 

 
TEMPORARY MEMBERS (Voting)  
 
Carola Arndt, MD 
Professor of Pediatric Oncology  
Mayo Clinic  
Rochester, Minnesota 
 
Diane M. Biskobing, MD 
Professor of Medicine  
Department of Medicine, Division of 
Endocrinology 
Virginia Commonwealth School of Medicine  
Richmond, Virginia 
 

Susan Rice Broyles  
(Patient Representative) 
Aledo, Texas 
 

Daniel Gillen, PhD 
Professor 
Department of Statistics 
University of California 
Irvine, California 
 

Susan R. Heckbert, MD, PhD 
Professor 
Department of Epidemiology 
University of Washington 
Seattle, Washington 
 
 
 

Julia Lewis, MD 
Professor of medicine 
Vanderbilt University  
Nashville, Tennessee 

Kevin McBryde, MD  
Program Director  
Office of Minority Health Research 
Coordination (OMHRC)   
National Institute of Diabetes & Digestive & 
Kidney Diseases (NIDDK) 
National Institutes of Health (NIH) 
Bethesda, Maryland 
 
Martha Nason, PhD 
Mathematical Statistician 
Biostatistics Research Branch, Division of 
Clinical Research 
National Institute of Allergy and Infectious 
Diseases, NIH 
Bethesda, Maryland 
 
Thomas J. Weber, MD 
Training Program Director, Endocrinology, 
Diabetes and Metabolism 
Division of Endocrinology, Metabolism and 
Nutrition 
Duke University Medical Center 
Durham, NC 
 
Lee S. Weinstein, MD 
Acting Chief, Metabolic Diseases Branch 
NIDDK, NIH   
Bethesda, Maryland 

 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

September 12, 2014 

 

 

MEETING ROSTER (cont.) 

 

 
 
Jean-Marc Guettier, MD, CM 
Director  
Division of Metabolism and Endocrinology 
Products (DMEP), ODE II, OND, CDER, FDA 
 
Naomi Lowy, MD  
Medical Officer 
DMEP, ODE II, OND, CDER, FDA  
 
 

 
FDA PARTICIPANTS (Non-Voting) 
 
Curtis J. Rosebraugh, MD 
Director 
Office of Drug Evaluation II (ODE II) 
Office of New Drugs (OND), CDER, FDA 
 
Dragos Roman, MD  
Clinical Team Leader 
DMEP, ODE II, OND, CDER, FDA 
 
Manoj Khurana, PhD 
Clinical Pharmacology Reviewer 
Division of Clinical Pharmacology II (DCP II) 
Office of Clinical Pharmacology (OCP) 
Office of Translational Sciences (OTS) 
CDER, FDA 
 

 
 
 
 

 

Page 3 of 3 

